Growth hormone (GH) and insulinlike growth factor (IGF) promote aging and age-related pathologies. Inhibiting this pathway by targeting IGF receptor (IGF-1R) is a promising strategy to extend life span, alleviate age-related diseases, and reduce tumor growth. Although anti-IGF-1R agents are being developed, long-term effects of IGF-1R blockade remain unknown. In this study, we used ubiquitous inducible IGF-1R knockout (UBIKOR) to suppress signaling in all adult tissues and screened health extensively. Surprisingly, UBIKOR mice showed no overt defects and presented with rather inconspicuous health, including normal cognition. Endocrine GH and IGF-1 were strongly upregulated without causing acromegaly. UBIKOR mice were strikingly lean with coordinate changes in body composition and organ size. They were insulin resistant but preserved physiological energy expenditure and displayed enhanced fasting metabolic flexibility. Thus, long-term IGF-1R blockade generated beneficial effects on aging-relevant metabolism, but exposed to high GH. This needs to be considered when targeting IGF-1R to protect from neurodegeneration, retard aging, or fight cancer. (Endocrinology 158: 2269(Endocrinology 158: -2283(Endocrinology 158: , 2017 
I
nsulin-like growth factors (IGFs) and their cognate tyrosine kinase receptor [IGF receptor (IGF-1R)] play pivotal roles in the physiology of vertebrate organisms, notably by regulating somatic growth, development, and metabolism. This was elegantly demonstrated using null mutants for IGF ligand and receptor genes that displayed severe growth deficiency, including neonatal lethal lung and muscle hypoplasia, typical of homozygous IGF-1R knockout (KO) (1, 2) . The overall importance of IGF signaling during embryogenesis and postnatal organ development led to the general view that stimulation of the IGF-1R pathway correlates positively with health and improved fitness. However, this view was challenged by studies demonstrating that IGF signaling negatively impacts life span by promoting a variety of aging processes and accelerating the progression of age-related diseases, now widely perceived as the possible downsides of enhanced growth stimulation. Indeed, constitutive heterozygous IGF-1R deletion prolongs life span in mice and in various other species (3) (4) (5) (6) (7) (8) . Consistently, heterozygous loss-of-function mutations in the human IGF-1R gene were found overrepresented among centenarians, suggesting that diminished signaling in the IGF pathway is also associated with human longevity (9) . Much argues in favor of cell-autonomous effects of IGF-1R inactivation causing the longevity phenotypes. For instance, genetic deletion of IGF-1R targeted to neurons of the central nervous system promotes neuroprotection against stroke and alleviates Alzheimer's disease (10) (11) (12) (13) . Significantly, IGF-1R activity has been discussed for many years in the context of tumorigenesis and malignancy, many of which are age-related pathologies as well. This led to the development of various anti-IGF-1R agents, such as blocking antibodies, modified ligands, and small tyrosine kinase inhibitors for therapeutic purposes (14, 15 ). Yet, clinical trials targeting IGF-1R did not readily yield the desired benefits (e.g., in human cancer treatment) (16) (17) (18) . Interestingly, the rather disappointing results of clinical trials have been ascribed to insufficiencies of the new molecules, the selection of specific types of cancer, or to the still incomplete knowledge of the complexity of IGF-1R pathways and potential compensatory signaling (19) (20) (21) (22) .
The prospect to promote beneficial effects on health span by limiting the impact of somatotropic signaling on aging and age-related diseases explains the growing interest in pharmacological interventions that efficiently interfere with IGF signaling in adult individuals (23, 24) . Because of its singular and highly specific role in IGF signal transduction, IGF-1R is an attractive drug target. However, the consequent use of anti-IGF-1R agents requires detailed knowledge of the physiological and in particular metabolic consequences of blocking the IGF pathway on the level of the entire organism and over long periods of adult life and aging. That knowledge is still very incomplete. Thus, to gain more comprehensive insight into the principal physiological effects of shutting down IGF signaling in vivo, we generated adult-onset homozygous IGF-1R gene KO in mice and explored the resulting mutant phenotype. We took advantage of the first highly efficient ubiquitous inducible Cre transgenic mouse (25, 26) allowing efficient postnatal disruption of IGF-1R gene expression [ubiquitous inducible IGF-1R KO (UBIKOR) mice]. In this work, we report that ubiquitous, long-term inhibition of IGF-1R signaling, when performed in adult mice, is essentially compatible with normal health and physiology. Despite altered body composition and elevated glycemia, UBIKOR mice also exhibited several beneficial traits, together suggesting cognition and neuromuscular performance were intact. UBIKOR mice presented with a lean habitus and revealed resilient energy metabolism (e.g., when exposed to reduced availability of food). Finally, this study also revealed that ubiquitous long-term suppression of IGF signaling triggers swift endocrine upregulation of pulsatile growth hormone (GH) secretion. This work broadly expands our understanding of the role of IGF signaling during adult life and aging, and provides important experimental evidence suitable to guide the development of therapies targeting the IGF-1R signaling. and Igf1r flox/flox mice received Tam, and were referred to as UBIKOR and control, respectively. Mice were weighed before and after Tam administration, daily for 1 month, and every 2 weeks thereafter. Comparative growth charts with curves of mean weight 6 standard deviation (SD) were established from Tam-treated controls. Male reproductive behavior was checked by mating each mutant or control male with two wild-type females for 20 weeks, monitoring pregnancies. Female reproductive performance was assessed mating UBIKOR and control females with wild-type males for 20 weeks. Mating was started 1 month after KO induction.
Materials and Methods

Animals
Behavior
SmithKline Beecham, Harwell, Imperial College, Royal London Hospital phenotype assessment (SHIRPA) was performed, as described (29, 30) , to screen behavior, neurology, health, and physiology. Open field test, two-trial Y-maze and Barnes maze (learning, memory), were performed as described (13) . Spontaneous alternation behavior in Y-maze was used to measure responsiveness to novelty. Y-maze arms were 40 cm long, 8 cm wide, with 16-cm-high opaque walls. The sequence of successive entries into arms and total distance traveled were recorded for 5 minutes. O-maze test assessed anxiety, as described (31) . The elevated, 8-cm-wide circular runway of 75 cm outer diameter comprised two opposite 90°sectors laterally protected by opaque, 20-cm-high walls, and two (intercalated) 90°sectors that were unprotected and therefore anxiogenic. Mice started in protected sectors. Total number of entries into protected and anxiogenic zones, time spent, and distance traveled were recorded for 5 minutes. All behavioral tests used video tracking (Biobserve, St. Augustin, Germany) for recording and analyses.
Neuromuscular assessment and actimetry
Rotarod (UgoBasile, Milan, Italy) and photoelectric actimeter (Imetronic, Pessac, France) were used as described (13, 31) . Combined forelimb and hind limb grip strength was measured following manufacturer's instructions (Bioseb, Vitrolles, France). Peak force was recorded in three consecutive measurements, the procedure was repeated 2 hours later, and all six measurements were averaged. For wire-hanging test (32), mice were placed on a cage lid that was gently moved to make the mice hold firmly onto the wire bars. The lid was then swiftly turned upside down, 30 cm above a cushioned area. Latency to fall off was recorded, and the challenge was limited to 6 minutes.
Glucose metabolism, biochemistry, and hormones
Glucose tolerance was tested [glucose tolerance test (GTT)] in 14-hour-fasted mice. Capillary glycemia was measured using OneTouch Ultra (LifeScan, Milpitas, CA) for 2 hours after IP injection of 2 g kg 21 BW glucose. Insulin secretion, basal and 30 minutes after IP glucose, was determined in 14-hour-fasted mice using mouse insulin enzyme-linked immunosorbent assay (ELISA; EZRMI-13K; Merck Millipore, Molsheim, France). For insulin tolerance test, mice were 5-hour-fasted, received insulin IP (females 0.6 U, males 0.8 U per kg BW), and had glycemia monitored for 2 hours. Plasma (EDTA) was obtained from retro-orbital sinus blood and stored at 280°C. To estimate whole-body insulin resistance, homeostasic model assessment of insulin resistance was calculated as fasting glycemia (mg dL 21 ) 3 insulinemia (IU L
21
)/405 (33) . Blood for GH ELISA (EZRMGH-45K; Merck Millipore) was sampled within 20 seconds after first moving cages to exclude stress effects (7, 34) . Samples (two to three per animal) were drawn between 5 and 7 PM, with a 7-day interval between punctures. Total IGF-1 was determined using mouse IGF-1 Quantikine ELISA (MG100; R&D Systems, Minneapolis, MN). Retro-orbital blood for hematology was collected in EDTA and analyzed using a MS9-5V hemocytometer (Melet Schloesing, Osny, France). Plasma biochemistry was analyzed using AU400 (Olympus, Paris, France). Spontaneous urine was collected from a clean glass surface and stored at 220°C. Urinalysis (density, pH, glucose, bilirubin, ketone bodies, blood, protein, urobilinogen, nitrites, and leukocytes) was performed using Multistix 10SG and Clinitek Status (Siemens Health Care, Erlangen, Germany).
Food intake, body composition, activity, and energy expenditure Ad libitum food intake was measured for 5 days. For each 24-hour interval, intake was determined measuring remaining and dispersed food, and expressed in grams per mouse. Fat and lean body mass were determined by dual-energy X-ray absorptiometry (DEXA) using Lunar PIXImus (GE Health Care, Vélizy-Villacoublay, France). Results were used to establish active metabolic mass (AMM = fat-free mass + 0.2 3 fat mass) (35) (36) (37) . Components of energy expenditure were obtained by indirect calorimetry and expressed per AMM. O 2 consumption (VO 2 ) and CO 2 production (VCO 2 ) were measured for 3 days in individual calorimetric cages with free access to food and water. Mice were habituated for 24 hours, and caloric intake and spontaneous motor activity (simply called "activity" later) were measured during the next 48 hours (36). Total energy expenditure (TEE) was calculated using Weir's equation (TEE = 16.3 VO 2 + 4.57 VCO 2 ) from measurements conducted every 10 minutes for 48 hours (36, 38) . TEE was averaged and expressed in kilojoules per day per AMM. Respiratory quotient (RQ) is VCO 2 /VO 2 . Relative cumulative frequency (RCF) curves were generated from serial RQ data (39) . Activity was continuously recorded using a piezoelectric device and corrected for BW. A cycle of fasting-refeeding was imposed to refine metabolic analysis. Mice were fasted for 16 hours with free access to water in metabolic cages at constant 30°C to reduce thermoregulation energy expenditure to zero, and refed with 1.0 g calibrated food (13.1 kJ). Gas exchange and activity were recorded for 10 hours before and 6 hours after meal serving. Data were acquired in 2-second intervals to allow analysis of changes in total metabolic rate induced by activity, and were used to determine energy cost of activity and resting metabolic rate while animals were freely moving (36) . Thermal effect of feeding (kilojoules) was computed from meal-induced changes in resting metabolic rate. Measurements of energy expenditure and DEXA were carried out exclusively in males.
Anatomical dissection and sample collection
Mice received IP 150 mg kg 21 BW pentobarbital. Naso-anal distance was measured, and, after transcardial phosphatebuffered saline perfusion, mice were decapitated, and cerebral cortex, hippocampus, olfactory bulb, pituitary gland, and cerebellum were dissected and weighed. Skin, skeletal muscle, heart, lungs, thymus, liver, kidneys, adrenal gland, pancreas, spleen, bladder, reproductive organs, and gastrointestinal tract were prepared and weighed. Selected tissues, including liver (left lobe), were fixed in 4% paraformaldehyde, frozen, and stored at 280°C. Left femur and tibia were cleaned for morphometry, and right hind limb was paraformaldehyde-fixed for histology. Subcutaneous (inguinal/dorsolumbar, interscapular) and visceral (retroperitoneal, mesenteric, perigonadal) white adipose tissue (AT) was quantitatively collected, and total AT weight was used to determine lean weight from BW. Weight of organs was expressed relative to lean weight.
Morphometry and histology
For bone morphometry, tibia and femur were weighed and measured with an electronic caliper. Shaft cross-section area was determined from mediolateral and anteroposterior diameter at middiaphysis, and femur was weighed again after 2 weeks at dry 70°C. Decalcified femurs were embedded in paraffin, and 5-mm sections were stained with hematoxylin phloxine saffron (HPS). Per animal, six frontal sections, clustered within 60 mm of the midline, were imaged with a Leica DM5000B microscope and used for morphometric analysis (Fiji software) (40) of femur head. Femur head surface was considered as the mean area between growth plate and proximal borders of femur head. Trabecular bone area fraction (bone/ femur head surface), mean trabecula thickness, separation, and density were determined using the Map_BoneMicrostructure plug-in. Cortical bone thickness was measured from transverse sections at middiaphysis. Bone mineral content and density of whole body and femur were analyzed by DEXA in anesthetized mice, following the manufacturer's instructions.
For liver histopathology, 5-mm sections of paraffinembedded liver biopsies were stained by HPS, and surface area of lymphocytic infiltration was determined from seven randomly taken microscopic fields per animal. For immunohistochemistry, sections were incubated with rabbit anti-mouse Iba1 (019-19741, 1:1000; Wako, Osaka, Japan; RRID: AB_839504) and secondary goat anti-rabbit Alexa 594 (A11012, 1:2000; Thermo Fisher Scientific; RRID: AB_10562717) and counterstained with 4 0 ,6-diamidino-2-phenylindole (DAPI). Prevalence of positive cells was averaged from six microscopic fields per section. Size distribution of HPS-stained cell nuclei was evaluated using Fiji from eight fields around a central vein.
For brain histology, sagittal cryostat sections from neocortex were stained with DAPI, and cell nuclei were counted automatically from micrographic images (three per mouse) using the Simple Morphological Image Library (Center for Mathematical Morphology, http:// cmm.ensmp.fr/~faessel/documents/2013_03_SMIL_LRDE.pdf). The blue channel was extracted from each image, and all local maxima identified using open and hMaxima functions. Boundaries were determined using a watershed approach (dist, inv, hDualBuild, and watershed) and subtracted from the local maxima, and each segment was colored differently [Supplemental Fig 
Statistical analysis
We analyzed data using Prism (GraphPad, San Diego, CA) and reported mean 6 standard error of the mean. MannWhitney U test was used for nonparametric unpaired and Wilcoxon matched pairs test for paired data. Analysis of variance with Tukey post hoc test was used as indicated. Repeated measures analysis of variance was combined with post hoc multiple Student t test. Log-rank test was used to compare ranked GH distributions (34) . Levels of significance were *P # 0.05, **P , 0.01, ***P , 0.001; not significant (NS), P . 0.05.
Results
Preweaning induction of IGF-1R KO severely blunts somatic growth in mice
To demonstrate the efficiency of ubiquitous IGF-1R inactivation in tissues, we first treated 6-day-old UbcCreER 
Efficient Igf1r gene deletion in adult mice
To exclude developmental effects of IGF-1R deletion in subsequent experiments, we induced ubiquitous IGF-1R KO at age 3 months and called this conditional mutant UBIKOR. Genotyping all tissues 2 months after Tam showed average gene excision of 93% 6 1.2, a proportion stable for $15 months (Supplemental Fig. 2 ). Genotyping offspring of UBIKOR mating revealed 100% (62/62) transmission of Igf1r null alleles, indicating efficient Cre-lox excision also in the germline. Of note, among a total of 35 UBIKOR, we identified four with clearly lower (,77%) and obviously incomplete genetic excision of floxed Igf1r alleles that we excluded from the study, solely for this reason. Phenotypic changes reported in this study were similar in males and females, and we therefore combined the data, except where indicated (reproductive performance, energy expenditure).
Ubiquitous loss of IGF-1R in adults upregulates endocrine GH and IGF-1
In UBIKOR, the peak and intermediate levels of GH were significantly increased, whereas troughs were at the detection limit in UBIKOR and in controls, together indicating enhanced pulsatile GH secretion in mutants [ Fig. 1(h) ]. Consistently, circulating IGF-1 was markedly increased in UBIKOR [ Fig. 1(i) ], suggesting diminished negative feedback in neuroendocrine hypothalamus and pituitary in response to induced IGF-1 resistance. Hence, it can be assumed that, in the absence of IGF-1R, UBI-KOR tissues were exposed lifelong to high GH pulses.
General health and behavior in UBIKOR mutant mice
To determine short-and long-term impact of adult-onset ubiquitous IGF-1R KO on health, we first conducted a SHIRPA screen. One month after Tam administration, UBIKOR and control mice performed adequately in all 42 behavioral and sensorimotor SHIRPA tasks (Supplemental Table 2 ). No significant differences prevailed, except that controls were better in visual placing task. Repeated at 22 months, SHIRPA revealed persistent good health for both groups and little additional changes, including modifications of skin and fur, and fewer spontaneous movements, which were somewhat more pronounced in UBIKOR. Nevertheless, control and mutant mice were similarly active in open field [Supplemental Fig. 3(A-C) ] as well as in 24-hour actimeter tests, whether comparing circadian profiles [Supplemental Fig. 3(D control n = 23, UBIKOR n = 10).
UBIKOR conditions lean habitus and differentially impacts organ size
Body composition by DEXA revealed that UBIKOR had significantly less body fat than controls, whereas lean mass was similar (Supplemental Table 4). Anatomical dissection confirmed UBIKOR mice had strikingly less AT (242%, P , 0.01), with both visceral and subcutaneous AT compartment being significantly reduced [ Fig. 2(a) ; Supplemental Table 5 ]. Dissection also showed that adultonset IGF-1R KO affected organ size differentially. Wet weight of several organs was clearly reduced after IGF-1R inactivation, notably hind limb muscle and bones, lungs, and brain [ Fig. 2(b) ; green shadings; lung: control Table 6) . Surprisingly, in UBIKOR mice, several other organs, namely liver, pancreas, heart, gastrointestinal tract, kidney, and bladder, increased significantly in size [ Fig. 2(b) , red shadings]. Skin tended to be thinner in UBIKOR mice, and a few other tissues showed no effect (e.g., the muscles of forelimbs) (Supplemental Table 6 ).
Altered metabolic regulation
Markedly diminished body fat in UBIKOR mice pointed to altered nutrition and metabolism. With daily food intake being identical in UBIKOR and controls (Supplemental Table 4 ), we next explored TEE, resting metabolic rate, and RQ by indirect calorimetry in ad libitum fed mice. This confirmed unchanged activity, identical TEE and RQ, and excluded major alterations of metabolism (Supplemental Table 4 ). In UBIKOR and control mice, RQ was close to 1.00 during dark period and significantly lower (0.96) during light period [ Fig.  3(a) and 3(b) ], indicating normal alternation between carbohydrate and protein/lipid oxidation, with some nocturnal lipogenesis in UBIKOR and controls. Interestingly, post hoc analysis of RCF of RQ revealed significantly reduced slope of RCF curves in UBIKOR mice, indicative of improved metabolic flexibility [ Fig. 3(c) ]. Together, these results suggested that, under ad libitum conditions, metabolic homeostasis was preserved and specific aspects improved in UBIKOR mice. We next performed a controlled refeeding at thermoneutrality after 12-hour fasting, to distinguish between energy cost of activity and resting metabolism, and to measure feeding thermogenesis. Time courses of resting RQ and resting metabolic rate (adjusted for AMM) were similar in both groups during fasting and refeeding [ Fig. 4(a) and  4(b) ]. In contrast, RQ linked to activity was significantly higher in UBIKOR mice during fasting, and energy cost of activity was also clearly increased in mutants during most of the experiment [ Fig. 4(c) and 4(d) ]. On average, this significant difference represents a 25% increase in energy cost of activity (Supplemental Table 7 ) during fasting and also during refeeding. This difference decreased during the last 4 hours before the meal, when mice were already 12-hour-fasted. Moreover, evolution of RQ and energy cost during activity strongly suggested differences between both groups in the control of muscle energy metabolism, especially during fasting [ Fig. 4(c) and 4(d) ].
Because IGF signaling controls several aspects of energy metabolism, we focused on glucose homeostasis in fed and fasted animals. Importantly, glycemia was significantly increased in ad libitum fed UBIKOR mice [+21%, P , 0.01; Fig. 5(a) ] and remained elevated, even after a 14-hour fast and regardless of age [ Fig. 5(b) ]. GTT revealed that UBIKOR mice were less glucose tolerant than controls [ Fig. 5(c) ]. Interestingly, during GTT, significant insulin secretion occurred in both groups. Yet, in UBIKOR mice, insulin tended to be high before (in the 14-hour-fasted mice) and 30 minutes after the glucose load [ Fig. 5(d) ]. These results could indicate facilitated insulin response to hyperglycemia in mutants, possibly resulting from the increased size of UBIKOR pancreases. Moreover, insulin tolerance test revealed a significantly abrogated hypoglycemic response in UBIKOR mice: by 60 minutes, controls showed 55% diminished glycemia, compared with 40% decrease in UBIKOR, and UBIKOR (control n = 25, UBIKOR n = 10). Blood was sampled within 20 seconds after first moving cages to exclude effects of stress (7, 34) . Inset details GH results #2 ng mL 21 . Groups differ significantly (P , 0.05, log-rank test). (i) Plasma IGF-1 (control n = 23, UBIKOR n = 10, age 15 months). ***P , 0.001, Student t test. Table 6 ). ad, adrenals; bld, bladder; br, brain; conn, connective tissues; fe, femur; fore, forelimb; gas, gastrocnemius; gi, gastrointestinal tract; he, heart; hind, hind limb; ki, kidneys; liv, liver; lu, lungs; mas, masseter; pa, pancreas; pit, pituitary gland; qua, quadriceps; spl, spleen; thy, thymus.
glycemia also returned faster to normal [ Fig. 5(e) ]. Finally, we evaluated insulin resistance using homeostasic model assessment of insulin resistance and found it clearly increased in UBIKOR mice (control 3.9 6 1.1, n = 21 vs UBIKOR 6.0 6 1.7, n = 7, P , 0.05). Together, these results evidenced moderate hyperglycemia in UBI-KOR and suggested some degree of insulin resistance. As an additional metabolic challenge, we eventually performed caloric restriction to 50% of ad libitum dietary intake, provoking identical weight loss in both groups. Importantly, 3 weeks of caloric restriction diminished the observed fed state hyperglycemia in UBIKOR to wildtype levels [ Fig. 5(f) ].
UBIKOR livers are oversized
Ubiquitous deletion of IGF-1R markedly increased liver size (Supplemental Table 6 ). We were therefore alerted by reports on liver inflammation and neoplasias in inducible liver IGF-1-deficient mice, a mutant that exhibits analogous endocrine settings, notably high GH (41). However, analyzing livers from 17-month-old mice, we found essentially normal histoanatomy and normal circadian alternation between glycogen storage and depletion in UBIKOR and control groups. In both genotypes, we found minor focal infiltration of lymphocytes and few macrophages, located preferentially periportal, at least in UBIKOR mice [ Fig. 6(a) and 6(b) ]. Also, in both genotypes, we found isolated periportal necrosis and related features of interface hepatitis, but no fibrosis. Focal cell aggregates are typically found in aging livers (42) , yet, in UBIKOR and control mice, they accounted for just 0.061% 6 0.032 and 0.029% 6 0.026 of liver volume, respectively (control n = 7, UBIKOR n = 5, P , 0.05, Mann-Whitney U test). To identify resident macrophages, we used anti-Iba1 immunostaining, but found no difference in cell density (control 381 6 53 vs UBIKOR 396 6 62 mm
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, NS, Mann-Whitney U test) nor in average immunoreactivity (control 51 6 4 vs UBIKOR 49 6 6 arbitrary units, NS, Mann-Whitney U test), definitively excluding chronic parenchymal inflammation [ Fig. 6 (c) and 6(j)]. To check for liver cell integrity, we measured aspartate aminotransferase, alanine aminotransferase, and alkaline phosphatase, yet they were not modified, confirming normal liver status in mutants and controls (Supplemental Table 8 ). Finally, because GH can enlarge hepatocyte nucleus, we evaluated nuclear size distribution, but found it unchanged [ Fig. 6 (c) and 6(d); Supplemental Fig. 5 ], again contrasting with the hepatic phenotypes of inducible liver IGF-1-deficient mice and other, specifically GH-overexpressing transgenic mice (41, 43) .
Light bones with unchanged trabecular structure
Because IGF-1 is also a known regulator of bone mass (44), we evaluated bone maintenance by osteometry, DEXA, and histomorphology. Femur length was unchanged, but wet and dry mass showed a 12% decrease in UBIKOR mice (Table 1) . Periostal circumference and shaft cross-section were also significantly decreased in UBIKOR, and distal femur head surface was lower. However, bone mineral content was unchanged, for femur alone as well as for the entire skeleton (Table 1) . Moreover, trabecular bone structure was similar in both genotypes [ Table 1 ; Fig. 6 (k) and 6(l)], just like cortical thickness at middiaphysis. Collectively, this showed that some aspects of bone morphology were affected by IGF-1R KO, whereas others, including trabecular structure, were fully preserved.
Smaller brain size and intact cognitive performance in UBIKOR mice
Diminished brain weight in UBIKOR mice (Supplemental Table 6 ) called for behavioral and cognitive evaluation. In the elevated O-maze, UBIKOR and controls showed similar propensity to fear [Supplemental Fig. 6(A) ]. With respect to cognition, different trials using the Y-maze paradigm demonstrated that immediate working memory was unaffected by the loss of IGF-1R [Supplemental Fig. 6(B) ; Fig. 7(a) ]. To extend on this, we also tested spatial learning and memory using the Barnes maze (13, (45) (46) (47) . Training improved learning in both groups, as evidenced by significant decreases in latency, distance traveled, and cumulative errors over days . Nonetheless, regression analysis of distance and cumulative errors did not reveal significant differences in slope. Thus, although initially slow, UBIKOR caught up and eventually learned as fast as controls. We next assessed long-term memory retention 1 and 7 days after acquisition. UBIKOR and controls performed equally, suggesting no effect of ubiquitous IGF-1R KO on mid-and long-term memory [ (Fig. 7(e) ]. Concerning search strategy to solve the maze, UBIKOR and controls had comparable propensities for serial and spatial strategy [ Fig. 7(f) ]. Collectively, results indicated that ubiquitous inactivation of IGF-1R did not alter anxiety and left principal cognitive performances intact.
Discussion
We showed that efficient ubiquitous suppression of IGF-1R in adult mice produces a characteristic tissue-specific phenotype during adulthood and aging. Results demonstrated that the effects of adult-onset IGF-1R KO from all organs and tissues can be conspicuously different from the changes obtained by tissue-or cell type-specific IGF-1R KO (19, (48) (49) (50) (51) (52) (53) . Importantly, ubiquitous KO avoids mismatch of IGF signaling between tissues, which is typically the case when IGF-1R inactivation is restricted to single organs or tissues. Another possible explanation for the distinctive features of this KO phenotype lies in the powerful upregulation of GH in UBIKOR mutants that is usually not seen in mouse models with tissue-specific IGF-1R inactivation. Exceptions are IGF-1R KO in pituitary somatotrophs (54, 55) , neuron-specific IGF-1R ablation (11, 13) , and ectopic hypothalamic IGF-1R deletion (56) that all show selectively increased GH secretion. Excessive, but essentially pulsatile GH release, as we observed in this study, clearly demonstrates lifelong persistence of neuroendocrine feedback regulation along the somatotropic hormone axis, which is likely to be the basis of plasticity in systemic homeodynamics of growth, metabolism, and aging. Of important note, high GH peaks in UBIKOR did not entail acromegaly, most probably due to the genetic inactivation of immediately downstream signal transduction through IGF-1R. Important for translational use of the present results is that strongly upregulated endocrine GH is also occurring in human subjects, for instance during short-term treatment with IGF-1R antibodies (57) . Although longterm IGF-1R blockade generated beneficial effects on aging-relevant energy metabolism (discussed later), it also exposed the entire organism to high GH. Interfering with IGF signaling to protect from neurodegeneration, to retard aging, or to fight cancer therefore requires particular awareness with regard to the unwanted effects of increased GH. Collectively, the present assessment is highly relevant because of the growing interest in developing therapeutic anti-IGF-1R strategies that are de facto systemic approaches.
In this study, we demonstrated that ubiquituous deletion of IGF-1R in adults is compatible with postnatal life and reproduction, clearly contrasting with constitutive, classical neonatal lethal IGF-1R null mutation (2). Obviously, UBIKOR mutants did not lack any vital function. Nevertheless, adult UBIKOR swiftly adopted a markedly lean habitus. Ubiquitous IGF-1R null mutation induced in adults affected body composition without overtly compromising health, which is precious information regarding the relevance of these findings for human disease and aging. We would like to emphasize that some differences with respect to published cell type-specific IGF-1R inactivation can also be ascribed to developmental defects of tissue-specific IGF-1R KO, or to systemic, organismal adaptation to the various forms of experimental IGF resistance. We conclude from our data that numerous adult tissues are capable of modulating cell size and/or tissue homeostasis in response to IGF signals.
Ubiquitous inactivation of IGF signaling better tolerated than tissue-specific KO
Ubiquitous inactivation of IGF-1R altered body composition of UBIKOR mice, affecting specifically brain, bone, muscle, and liver. Reduced size of the brain in mutants draws the attention to possible interference with central nervous system function, yet analysis of DNA content (data not shown) revealed that UBIKOR brains present with the same . Area under the curve was significantly different (control 10,850 6 1211 vs UBIKOR 14,780 6 1503, P , 0.05, Mann-Whitney U test). *P , 0.05, **P , 0.01, ***P , 0.001. (f) Glycemia under long-term caloric restriction diminished to control levels. Control n = 9, UBIKOR n = 8; *P , 0.05, ***P , 0.001, Mann-Whitney U test. (c-f) Mice tested at age 13 months. Fig. 7) , at least in cortex, a structure that responds strongly to changes in IGF signaling (13, 58) . Thus, although UBIKOR brains are smaller, they do contain the same total number of cells than controls, and we deduced from these data that mutant brains most likely conserved wild-type neuronal complexity. This could also explain the absence of significant cognitive and behavioral consequences of reduced brain size in UBIKOR. Together, this suggests that smaller brains are predominantly the result of diminished cell size, without loss of cellular complexity, similar to our findings in neuronspecific suppression of IGF-1R (13, 58) . How UBIKOR cell homeostasis is modified in the brain remains to be analyzed, but we can hypothesize that not only neurons, but numerous other central or peripheral cell types, too, are at least to some degree affected in size and cellular morphology. Although femur weight, cross-section, and head surface were diminished in UBIKOR, bone remodeling occurred without affecting cortical thickness or trabecular support, suggesting a coordinated fit of skeletal structures to reduced BW after induction of ubiquitous IGF-1R deletion in adult mice. This result is also in line with work showing that contributions of IGF-1 signaling to bone maintenance are different in aged mice than during juvenile skeletal growth and development (59) . In fact, depletion of IGF-1 has been shown to be detrimental to the bone accrual during postnatal growth but not in adult mice or during aging, suggesting efficient temporal control of the contribution of IGF-1 on skeletal acquisition and maintenance (60) . This said, to further address long-term effects of IGF-1R KO on bone tissue, more advanced ages and refined osteomorphometry would be required. Interestingly, concomitant with bone remodeling, muscle mass moderately decreased, yet without affecting grip strength. Of note, neuromuscular coordination, as reflected by rotarod performance of UBIKOR, was slightly diminished. Several factors may influence motor coordination, including muscle mass, learning ability, and cardiopulmonary endurance. Further experiments are needed to determine whether ubiquitous IGF-1R deletion induced in adulthood compromised muscle function by altering myofibers, similarly to muscle-specific IGF-1R KO (49, 61) . At this point it seems reasonable to assume that the observed limited reduction in muscle mass is also an adaptive result to diminished BW in UBIKOR mice.
In this study, most tissues of meso-or ectodermal origin displayed diminished size upon IGF-1R inactivation, which was the case of brain, muscle, bone, skin, and connective tissue. This contrasted with organs of endodermal origin, namely liver and pancreas, that exhibited marked increases in size. Equivalent observations have been made in liver IGF-1-deficient (LID) mice (41) . However, those livers also showed inflammation and a significant increase in the hepatic tumor incidence. Careful dissection of UBIKOR at 17 months of age did not reveal any neoplastic disease, contrasting with LID mice that exhibited high incidence of fatal hepatocellular carcinoma. Despite the presence of limited liver inflammation that frequently occurs in aged mice (62) , UBIKOR livers functioned normally and exhibited similar Kupffer cell density compared with controls.
Moreover, hepatocyte nuclear size was unmodified in UBIKOR, also in sharp contrast to observations in LIDand GH-overexpressing mice (41, 43) . Because this increase in tumor incidence and nuclear size in association with high liver weight is most likely due to excess GH stimulation (63), we conclude that increased peak levels of GH in UBIKOR mice were not directly detrimental for liver function or lobular histoanatomy. The dissociation of GH and IGF signaling on the level of the target cells may play a decisive role in this phenotype. Taken together, at the hepatic level, ubiquitous disruption of IGF-1 signaling in UBIKOR mice led to better preservation of health than models of liver-specific inactivation suggested before. Thus, global downregulation seems better tolerated than unbalanced signaling status or mismatch, typical for tissue-specific KO.
Suppression of IGF-1R conditions leanness and protects from glucose dysregulation
Upon inactivation of IGF-1R, fat tissue diminished markedly, yet we did not see changes in food intake or energy expenditure. Interestingly, we detected an improved ability of UBIKOR to alternate between the different principal sources of dietary energy, namely fatty acids vs carbohydrates (39) . The circadian changes of RQ suggested that UBIKOR preferred metabolizing lipids instead of preserving them in adipocytes. This represents a metabolic management noticeably different from controls. These metabolic changes could be related to circulating GH levels, because several studies showed c Statistical significance of group differences determined by two-tailed Mann-Whitney U test.
e Similar results were obtained for tibia dry weight (P , 0.01; data not shown).
f P , 0.001.
g Control n = 8; UBIKOR n = 6. Results were obtained in males.
h Ratio of trabecular bone cross-section to femur head surface.
doi: 10.1210/en.2017-00261 https://academic.oup.com/endoGH treatment increases lipid oxidation, both in humans and rodents (64) . In agreement with the so-called lipolytic effect of GH, we found a predominant decrease of visceral AT in UBIKOR, as compared with subcutaneous AT. The moderate hyperglycemia observed in UBIKOR under ad libitum feeding and their mild insulin resistance observed after fasting could also be physiologically linked to endocrine GH, which is known to stimulate gluconeogenesis. However, systemic insulin resistance in UBIKOR mutants seemed less pronounced compared with what others reported from transgenic mice overexpressing GH (33) . In addition, UBIKOR mice did not show overt fasting hyperinsulinemia and displayed augmented, but still normal insulin secretion upon glucose administration. This demonstrated that ubiquitous disruption of IGF-1R signaling did not lead to metabolic features typical for obesity and/or manifest diabetic metabolic situations (65) . In fact, with the exception of the IRS-2 KO, the disruption of genes shared by IGF and insulin signaling pathways induces moderate insulin resistance without developing diabetes (66) . Pancreatic control of glucose homeostasis appeared conserved in UBIKOR, contrasting with mouse models of b-cell-specific deletion of IGF-1R that engendered glucose intolerance or diabetes (19, 52, 67) . Increased pancreatic mass in UBIKOR mice was most likely due to excess GH (68) , and we propose that compensatory organ hypertrophy protected mutants from overt glucose intolerance and hyperinsulinemia. Additional studies are needed to determine whether other markers of energy metabolism are altered in UBIKOR mice with oversized pancreas.
IGF signaling modulates energy metabolism during food restriction
We also analyzed the metabolic behavior of UBIKOR in a fasting/ refeeding experiment. During fasting, RQ activity indicated that lipid oxidation was predominant in controls, suggesting that UBIKOR preferred carbohydrate oxidation for muscle activity-related energy expenditure, instead of using stored lipids. Upon onset of the refeeding meal, activity RQ was similar in both groups, suggesting that UBIKOR and control mice used preferentially immediately available dietary carbohydrates for muscle cell metabolism. The meal-induced increase in resting metabolic rate was identical in UBI-KOR and control mice, indicating no difference in mealinduced thermogenesis. As expected, energy cost of activity of both groups varied over time in relation with their fasted vs fed status. Significant differences of energy cost of activity were found between UBIKOR and controls. This strongly suggested a differential biological Control n = 33, UBIKOR n = 24; four trials per day for 4 days. Repeated measures analysis of variance for latency (P = 0.01 for genotype, P , 0.001 for day, P , 0.05 for interaction); for distance traveled (P = 0.21 for genotype, P , 0.001 for day, P = 0.32 for interaction); and for cumulative errors (P = 0.07 for genotype, P , 0.001 for day, P = 0.16 for interaction) followed by post hoc multiple t test (*P , 0.05). (e) Memory retention assessed on day 5. (f) Prevalence of spatial, serial, and random search strategies on day 5. Identical results for (e) and (f) were obtained 7 days later (data not shown). Lack of difference between groups indicated normal short-and long-term memory in UBIKOR.
efficiency of the coupling between oxygen consumption and adenosine triphosphate synthesis in working muscles, because no differences in activity existed between animals despite their large differences in adiposity.
Collectively, ubiquitous inactivation of IGF-1 receptors in adults led to tissue remodeling without affecting major biological functions. The main consequences observed in UBIKOR were a strong mobilization of fat tissue and better adaptation to the metabolic consequences of food restriction. Indeed, UBIKOR mice appeared to be very well adapted to fasting conditions. Interestingly, metabolic alterations reminiscent of the UBIKOR phenotype presented in this work were recently described in IGF-1-deficient mice that are insulin resistant and seem protected from the deleterious effects of high-fat feeding (69) . One may predict from all these findings that interventions blocking IGF-1 signaling could be beneficial in terms of health span especially in environments where high-fat or otherwise highcalorie diets are endemic, as is the case for humans in most modern societies.
